BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26506944)

  • 1. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
    Wang Y; Liu Z; Zou W; Hong H; Fang H; Tong W
    Biomark Med; 2015; 9(11):1189-200. PubMed ID: 26506944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Micro-managers' of hepatic lipid metabolism and NAFLD.
    Liu W; Cao H; Yan J; Huang R; Ying H
    Wiley Interdiscip Rev RNA; 2015; 6(5):581-93. PubMed ID: 26198708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
    Hochreuter MY; Dall M; Treebak JT; Barrès R
    Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
    Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.
    Liu XL; Cao HX; Fan JG
    J Dig Dis; 2016 Nov; 17(11):708-715. PubMed ID: 27628945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury.
    Markovic J; Sharma AD; Balakrishnan A
    Cells; 2020 Jul; 9(8):. PubMed ID: 32717951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Kato J; Tokunaga S; Sugihara TA; Hara Y; Hino K; Murawaki Y
    PLoS One; 2016; 11(5):e0154676. PubMed ID: 27135827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
    Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
    Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis.
    Katsura A; Morishita A; Iwama H; Tani J; Sakamoto T; Tatsuta M; Toyota Y; Fujita K; Kato K; Maeda E; Nomura T; Miyoshi H; Yoneyama H; Himoto T; Fujiwara S; Kobara H; Mori H; Niki T; Ono M; Hirashima M; Masaki T
    Int J Mol Med; 2015 Apr; 35(4):877-84. PubMed ID: 25672270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
    Fang Z; Dou G; Wang L
    Int J Biol Sci; 2021; 17(7):1851-1863. PubMed ID: 33994867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in fatty liver disease.
    Sobolewski C; Calo N; Portius D; Foti M
    Semin Liver Dis; 2015 Feb; 35(1):12-25. PubMed ID: 25632931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH.
    Cariello M; Piccinin E; Moschetta A
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1519-1539. PubMed ID: 33545430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNAs associated with nonalcoholic fatty liver disease.
    Atic AI; Thiele M; Munk A; Dalgaard LT
    Am J Physiol Cell Physiol; 2023 Feb; 324(2):C588-C602. PubMed ID: 36645666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
    Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
    Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs in non-alcoholic fatty liver disease.
    He Z; Hu C; Jia W
    Front Med; 2016 Dec; 10(4):389-396. PubMed ID: 27680976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice.
    Rodrigues PM; Afonso MB; Simão AL; Carvalho CC; Trindade A; Duarte A; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM; Castro RE
    Cell Death Dis; 2017 Apr; 8(4):e2748. PubMed ID: 28406477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.
    Torres JL; Novo-Veleiro I; Manzanedo L; Alvela-Suárez L; Macías R; Laso FJ; Marcos M
    World J Gastroenterol; 2018 Sep; 24(36):4104-4118. PubMed ID: 30271077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.